Our work is the first to prove that additional insulin based on a modified FPU algorithm (200 kcal protein or fat equaling 10 g carbohydrates) can be safely administered before a high-fat, high-protein meal in adults with type-1 diabetes using MDI therapy without raising the risk of hypoglycemia. This evidence concerns the gene INS and type 1 diabetes mellitus.